IT-05 ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION

INTRODUCTION: Recurrent high grade glioma (rHGG) remains one of the most deadly cancers. Investigational agents Toca 511, a retroviral replicating vector, and Toca FC (extended-release 5-FC) are used in combination to target residual tumor at the time of resection. METHODS: This study (NCT01470794)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cloughesy, Timothy F., Kesari, Santosh, Kalkanis, Steven, Mikkelsen, Tom, Landolfi, Joseph, Elder, J. Bradley, Liau, Linda M., Chen, Clark C., Bloomfield, Stephen, Piccioni, David, Chiocca, E. Antonio, Foltz, Greg, Robbins, Joan M., Ostertag, Derek, Jolly, Doug J., Ibañez, Carlos, Pertschuk, Dan, Pan, Christine, Vogelbaum, Michael A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218255/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares